Glioblastoma multiforme is a very aggressive cancer with a dismal prognosis.Nevertheless, a promising therapeutic strategy is to induce tumour cell deathvia tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-basedtherapy that binds to human death receptor 4 (DR4). Here, TNFRSF10A is linked to glioblastoma.